Conclusion
Our findings add to the growing evidence that SES and health care coverage are strong prognostic factors that influence the stage of presentation for children and AYA with sarcoma, potentially reflecting decreased access to care for these patients and families. Further studies are needed in order to evaluate mechanisms that underlie these disparities so that interventions may be designed to improve outcomes in this population.